
Overview
Background
Professor Simon Cool is Professor of Bioengineering and Director of the UQ Advanced Cell Therapy Manufacturing Initiative in the School of Chemical Engineering at the University of Queensland.
Professor Cool began his scientific career at the University of Queensland more than 20 years ago. He received his BSc (hons) and PhD degrees from the University of Queensland, where he subsequently held a faculty position in the School of Biomedical Sciences. His areas of studies have included age-related changes in the structure of bone and teeth and the extracellular matrix compartment of skeletal tissue that guide stem cell behaviour and wound repair. Professor Cool was invited to join the Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore in 2003 as a Principal Investigator. He then joined A*STAR’s Institute of Medical Biology (IMB) in 2008, shortly after its inception, to further his research in regenerative medicine, serving as Senior Principal Investigator of the Glycotherapeutics Group. In October 2020, Professor Cool re-joined the Institute of Molecular and Cell Biology (IMCB) as a Research Director, Glycotherapeutics, where he focused on developing novel glycosaminoglycan biomolecules that enhance wound repair and control adult human mesenchymal stem cell activity.
Professor Cool has 117 patent applications across 26 families with 51 granted in the fields of glycosaminoglycan biochemistry, regenerative medicine and stem cell science. He has more than 150 publications and continues to foster strong strategic collaborations both nationally and internationally with academic and industry groups. He has a strong biomanufacturing and translational focus with experience in taking glycosaminoglycan-based devices through discovery RnD on to pre-clinical and clinical testing. Professor Cool also has an entrepreneurial and licensing background having successfully spun-off some of his technology to a US-based regenerative medicine start-up company, SMC Biotechnology Ltd. Professor Cool holds a Visiting Professor appointment at the Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore and an Adjunct Professor (Research) appointment in the Orthopaedic Department at the National University of Singapore (NUS). Prior to his move back to UQ, he previously held the position of Treasurer, Tissue Engineering and Regenerative Medicine International Society, Asia Pacific Chapter (TERMIS-AP) and Treasurer, Stem Cell Society Singapore (SCSS). He also held senior leadership positions in several Singapore-based R&D programmes, notably as Director, Allogeneic Stem Cell Manufacturing (ASTEM) and Theme Leader in Advanced Manufacturing for Biological Materials (AMBM). Prof Cool currently serves on the Editorial Board of the journals Biomaterials, Tissue Engineering and Regenerative Medicine, and is Asia-Pacific Regional Editor for Stem Cells and Development.
Availability
- Professor Simon Cool is:
- Available for supervision
Fields of research
Qualifications
- Bachelor of Science (Honours), unknown
- PhD, unknown
Research interests
-
Manufacturing highly-potent stem cells
Developing novel media, assays, and processes to enable the scale-up manufacturing of cell therapy products.
-
Rejuvenation of ageing stem cells
Developing innovative methods to rejuvenate ageing stem cells to generate best-in-class cell banks for therapeutic use.
-
Synthesis of glycosaminoglycans as medical devices
Developing scalable methods to manufacture fully synthetic glycosaminoglycans for use as media additives, biocoatings and medical devices for treating disease, injury or trauma.
-
Modification of stem cells to improve their therapeutic utility
Altering stem cell surfaces to encourage protein binding and drive stem cell fate decisions for improved therapeutic efficacy.
-
Enhanced angiogenesis through glycosaminoglycan administration and medical device formulation
Developing pro-angiogenic microenvironments using novel glycosaminoglycan formulations.
Research impacts
I have over 25 years of leadership in identifying novel heparan sulphate (HS) glycosaminoglycan (GAG) sugars within stem cell niches and repairing tissues. These sugars sequester, protect, hold, and present key growth factors to stem cells. I have successfully used this complexation paradigm to unlock pathways critical to stem cell biology, mainly signalling cascades essential for maintaining naïve phenotypes. I have also shown that this strategy effectively develops bioadditives for manufacturing cell therapy devices for treating vascular ischemia/stroke, cartilage regeneration, and bone repair. A significant part of this pioneering effort has been manufacturing HS variants that mimic sugars in native tissues. Anchoring this strategy is my novel discovery platform that identifies specific domains in HS chains that form complexes with growth factors and growth factor receptors to generate powerful signalling complexes that mediate cell-fate decisions and potentiate tissue regeneration. Using this blueprint, I have developed a library of bio-inspired HS variants and subjected them to structure/function analyses. I strongly advocate for the safety/tolerability testing of HS materials and continue to lead industry-based projects in this area. I have considerable experience leading outcome-focused multidisciplinary research teams across all scientific discovery and translation aspects, with a proven track record in developing transformative technology and biotechnology entrepreneurship. I lead a long-standing effort to bank mesenchymal stem cells cultured in HS-supplemented media to treat age-related diseases (pre-clinical stage only) and have been working to transition this project to a commercial facility to develop suitable manufacturing and banking protocols for future clinical testing. Through these various opportunities, I have mentored numerous PhD students in Australia, Singapore, and the UK, which has helped accelerate research opportunities and led to significant gains in generating novel findings.
Works
Search Professor Simon Cool’s works on UQ eSpace
2007
Journal Article
Glycosaminoglycan and growth factor mediated murine calvarial cell proliferation
Manton, KJ, Haupt, LM, Vengadasalam K, Nurcombe V and Cool SM (2007). Glycosaminoglycan and growth factor mediated murine calvarial cell proliferation. Journal of Molecular Histology, 38 (5), 415-424. doi: 10.1007/s10735-007-9121-6
2007
Journal Article
Heparan sulfate regulates the anabolic activity of MC3T3-E1 preosteoblast cells by induction of Runx2
Jackson, RA, Murali, S, Van Wijnen, AJ, Stein, GS, Nurcombe, V and Cool, SM (2007). Heparan sulfate regulates the anabolic activity of MC3T3-E1 preosteoblast cells by induction of Runx2. Journal of Cellular Physiology, 210 (1), 38-50. doi: 10.1002/jcp.20813
2007
Journal Article
Selection using the alpha-1 integrin (CD49a) enhances the multipotentiality of the mesenchymal stem cell population from heterogeneous bone marrow stromal cells
Rider, DA, Nalathamby, T, Nurcombe, V and Cool, SM (2007). Selection using the alpha-1 integrin (CD49a) enhances the multipotentiality of the mesenchymal stem cell population from heterogeneous bone marrow stromal cells. Journal of Molecular Histology, 38 (5), 449-458. doi: 10.1007/s10735-007-9128-z
2007
Journal Article
Osteogenic differentiation of murine embryonic stem cells is mediated by fibroblast growth factor receptors.
Woei Ng, K, Speicher, T, Dombrowski, C, Helledie, T, Haupt, LM, Nurcombe, V and Cool, SM (2007). Osteogenic differentiation of murine embryonic stem cells is mediated by fibroblast growth factor receptors.. Stem Cells and Development, 16 (2), 305-318. doi: 10.1089/scd.2006.0044
2007
Journal Article
Heparan sulfate control of proliferation and differentiation in the stem cell niche.
Nurcombe, V and Cool, SM (2007). Heparan sulfate control of proliferation and differentiation in the stem cell niche.. Critical Reviews in Eukaryotic Gene Expression, 17 (2), 159-171.
2007
Journal Article
Isolation of a native osteoblast matrix with a specific affinity for BMP2
Grunert, M, Dombrowski, C, Sadasivam, M, Manton, K, Cool, SM and Nurcombe, V (2007). Isolation of a native osteoblast matrix with a specific affinity for BMP2. Journal of Molecular Histology, 38 (5), 393-404. doi: 10.1007/s10735-007-9119-0
2007
Journal Article
Temporal and functional changes in glycosaminoglycan expression during osteogenesis.
Nurcombe, V, Goh, FJ, Haupt, LM, Murali, S and Cool, SM (2007). Temporal and functional changes in glycosaminoglycan expression during osteogenesis.. Journal of Molecular Histology, 38 (5), 469-481. doi: 10.1007/s10735-007-9123-4
2006
Journal Article
Characterisation and differentiation of porcine bone marrow mesenchymal stem cells in 2D and 3D mPCL-TCP-collagen scaffolds
Zhen, Chum Zhi, Woodruff, M. A., Sugunan, Suman Lal Chirammal, Cool, S. M., Nurcombe, V. and Hutmacher, D. W. (2006). Characterisation and differentiation of porcine bone marrow mesenchymal stem cells in 2D and 3D mPCL-TCP-collagen scaffolds. European Cells and Materials, 11 (S2), 82-82.
2006
Journal Article
Controlled release of heparin from poly(epsilon-caprolactone) electrospun fibers
Luong-Van, Emma, Grondahl, Lisbeth, Chua, Kian Ngiap, Leong, Kam W., Nurcombe, Victor and Cool, Simon M. (2006). Controlled release of heparin from poly(epsilon-caprolactone) electrospun fibers. Biomaterials, 27 (9), 2042-2050. doi: 10.1016/j.biomaterials.2005.10.028
2006
Conference Publication
Tailoring poly(3-hydroxybutyrate-co-3-hydroxyvalerate) for bone tissue engineering
Grondahl, L, Keen, I, Raggatt, L, Chandler-Temple, A. F., Cool, S M and Trau, M (2006). Tailoring poly(3-hydroxybutyrate-co-3-hydroxyvalerate) for bone tissue engineering. 28th Australasian Polymer Symposium & Aust Society for Biomat, Rotorua, 5-9 Feb, 2006.
2006
Journal Article
Heparan Sulfate Regulation of Progenitor Cell Fate
Cool, S M and Nurcombe, V (2006). Heparan Sulfate Regulation of Progenitor Cell Fate. Journal of Cellular Biochemistry, 99 (4), 1040-1051. doi: 10.1002/jcb.20936
2006
Journal Article
Sulfated Glycosaminoglycans Mediate the Effects of FGF2 on the Osteogenic Potential of Rat Calvarial Osteoprogenitor Cells
Ling,, Sadasivam,, Dombrowski,, Haupt, L. M., Stein,, Van Wijnen,, Nurcombe, V and Cool, S M (2006). Sulfated Glycosaminoglycans Mediate the Effects of FGF2 on the Osteogenic Potential of Rat Calvarial Osteoprogenitor Cells. Journal Of Cellular Physiology, 209 (3), 811-825. doi: 10.1002/jcp.20760
2006
Journal Article
Long-term loading inhibits ERK1/2 phosphorylation and increases FGFR3 expression in MC3T3-E1 osteoblast cells
Jackson, RA, Kumarasuriyar, A, Nurcombe, V and Cool, SM (2006). Long-term loading inhibits ERK1/2 phosphorylation and increases FGFR3 expression in MC3T3-E1 osteoblast cells. Journal of Cellular Physiology, 209 (3), 894-904. doi: 10.1002/jcp.20779
2006
Journal Article
Temporal expression of proteoglycans in the rat limb during bone healing
Song, J., Hutmacher, D., Nurcombe, V. and Cool, S. M. (2006). Temporal expression of proteoglycans in the rat limb during bone healing. Gene, 379, 92-100. doi: 10.1016/j.gene.2006.04.029
2006
Journal Article
Bone-Specific Heparan Sulfates Induce Osteoblast Growth Arrest and Downregulation of Retinoblastoma Protein
Manton, J., Sadasivam,, Cool, S M and Nurcombe, V (2006). Bone-Specific Heparan Sulfates Induce Osteoblast Growth Arrest and Downregulation of Retinoblastoma Protein. Journal Of Cellular Physiology, 209 (1), 219-229. doi: 10.1002/jcp.20727
2006
Journal Article
Coordinated fibroblast growth factor and heparan sulfate regulation of osteogenesis
Jackson, A, Nurcombe, V and Cool, S M (2006). Coordinated fibroblast growth factor and heparan sulfate regulation of osteogenesis. Gene, 379, 79-91. doi: 10.1016/j.gene.2006.04.028
2005
Journal Article
Substrate induction of osteogenesis from marrow-derived mesenchymal precursors
Cool, Simon M. and Nurcombe, Victor (2005). Substrate induction of osteogenesis from marrow-derived mesenchymal precursors. Stem Cells and Development, 14 (6), 632-642. doi: 10.1089/scd.2005.14.632
2005
Conference Publication
Parathyroid hormone stimulation of syndecan-4 in osteoblastic cells.
Raggatt, L. J., Qin, L., Cool, S., Nurcombe, V. and Partridge, N. (2005). Parathyroid hormone stimulation of syndecan-4 in osteoblastic cells.. 27th Annual Meeting of the American-Society-for-Bone-and-Mineral-Research, Nashville, TN USA, 23-27 September 2005. Hoboken, NJ USA: Wiley-Blackwell Publishing.
2005
Conference Publication
Poly(beta-hydroxybutyrate-co-beta-hydroxyvalerate) supports in vitro osteogenesis
Kumarasuriyar, A., Jackson, R. A., Grondahl, L., Trau, M., Nurcombe, V. and Cool, S. M. (2005). Poly(beta-hydroxybutyrate-co-beta-hydroxyvalerate) supports in vitro osteogenesis. New Rochelle: Mary Ann Liebert Inc. doi: 10.1089/ten.2005.11.1281
2005
Conference Publication
Characterisation of alginate and hydroxyapatite/alginate drug delivery systems
Grondahl, L., Lawrie, G. A. and Cool, S. M. (2005). Characterisation of alginate and hydroxyapatite/alginate drug delivery systems. Aust Society for Biomaterials 14th Annual Conference, Victor Harbor, Mar, 2005.
Funding
Past funding
Supervision
Availability
- Professor Simon Cool is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Fabrication of Sulfated Alginate Particles for Protein Delivery
Associate Advisor
Other advisors: Dr Ali Shokoohmand, Professor Lisbeth Grondahl
Completed supervision
-
-
2009
Doctor Philosophy
Heparan sulphate releasing biomaterials for tissue engineering
Principal Advisor
Other advisors: Professor Lisbeth Grondahl
-
2005
Doctor Philosophy
AUGMENTING OSTEOGENESIS THROUGH CHEMICAL AND MECHANICAL STIMULATION: THE USE OF LOADING AND HEPARAN SULFATE TO ENHANCE IN VITRO AND IN VIVO BONE FORMATION
Principal Advisor
-
2008
Doctor Philosophy
THE NOVEL ISOLATION OF HEPARAN SULFATE WITH A SPECIFIC AFFINITY FOR BONE MORPHOGENTIC PROTEIN 2
Associate Advisor
Other advisors: Associate Professor Peter Noakes
Media
Enquiries
For media enquiries about Professor Simon Cool's areas of expertise, story ideas and help finding experts, contact our Media team: